Ischemic heart disease in women may not show up on standard tests
Ischemic heart disease in women can lead to a heart attack, but this risk may go unnoticed. This is because a patient’s diagnostic coronary angiogram shows “clear” arteries. “When diagnosing women for ischemic heart disease, [...]
View more
Borderline hypertension poses myocardial dysfunction risks
Borderline hypertension or subclinical hypertension is a substrate for myocardial dysfunction, and patients can go for a long time with hypertension that isn’t clinically recognized, according to a heart failure specialist at Norton Heart & […]
View more
Hypertension in women and its consequences
The risks and consequences of hypertension in women differ from those in men and change throughout women’s lifetimes. Overall, hypertension in women is less prevalent than in men until age 60 and becomes more prevalent […]
View more
Norton Heart & Vascular Institute expands Women’s Heart Program
Norton Heart & Vascular Institute launched a Women’s Heart Program in 1995. Today it has expanded to include more providers and services for a region where heart disease, especially in women, is a deadly issue. [...]
View more
CT-FFR analysis shows patient’s level of cardiac obstruction and location, guiding treatment
The patient In July 2022, a 45-year-old male with a six-year history of chest pain went to the emergency room complaining of chest discomfort and shortness of breath over the previous two weeks. He was [...]
View more
Advances in hyperlipidemia medications put cholesterol goals in reach for more patients
Diet and exercise many times are not enough to lower the risk of hyperlipidemia (HLD). As we’ve learned over the years, genetics can play the biggest role. Fortunately, we now have treatments we didn’t have […]
View more
Advanced Heart Failure Referral Guidelines
When symptoms of heart failure begin progressing or patients start decompensating, there is a brief opportunity for referral to an advanced heart failure center. The American Heart Association calls this the “golden window.” Primary care […]
View more
Neurohormonal blockade in heart failure
Newly diagnosed heart failure patients have a three-month window of care crucial to their likelihood of recovery. The difference can be returning to a normal life versus awaiting a heart transplant or mechanical circulatory support […]
View more
Lauren R. Albers, M.D., joins Norton Heart & Vascular Institute to focus on women’s cardiology
Lauren R. Albers, M.D., has joined Norton Heart & Vascular Institute to focus on women’s cardiology. Dr. Albers, who completed her fellowship in cardiovascular medicine at the UofL School of Medicine, joins the Norton Heart […]
View more
Structural Heart Program offers multidisciplinary care
A new Structural Heart Program offers our patients a truly comprehensive approach, reducing the number of clinic visits and shortening the time from diagnosis to treatment. The Structural Heart Program is a combination of expertise […]
View more
Evidence growing in favor of ablation for atrial fibrillation
Ablation for paroxysmal atrial fibrillation (A-fib) has been shown to be superior to medical management for the maintenance of sinus rhythm. Now, newer ablation techniques are making the procedure safer, more efficient and effective. The [...]
View more
Treating amyloid cardiomyopathy (ATTR-CM) with tafamidis
New treatments are available for patients with transthyretin amyloid cardiomyopathy (ATTR-CM), a rare, underdiagnosed condition that causes faulty proteins to build up in the heart. Untreated, the condition leads to heart failure and death. An […]
View more